This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Watts, J L Articles by Case, C A Search for Related Content PubMed PubMed Citation Articles by Watts, J L Articles by Case, C A

 Previous Article  |  Next Article 

J Clin Microbiol. 1994 March; 32(3): 725-731

A 4-year survey of antimicrobial susceptibility trends for isolates from cattle with bovine respiratory disease in North America.

Upjohn Company, Kalamazoo, Michigan 49001.

ABSTRACT

The antimicrobial susceptibility trends of bovine respiratory disease (BRD) pathogens isolated from 1988 to 1992 were determined. A total of 880 isolates representing Pasteurella haemolytica, Pasteurella multocida, and Haemophilus somnus were used in the study. Overall, resistance to ampicillin, tetracycline, erythromycin, and sulfamethazine was frequently encountered among strains of P. haemolytica and P. multocida. Ceftiofur, an extended-spectrum cephalosporin originally marketed in 1988 for the treatment of BRD, was very active against the BRD pathogens tested; the MIC of ceftiofur for 90% of isolates tested was < or = 0.06 microgram/ml. Resistance to spectinomycin varied on the basis of the breakpoint used. Substantial variation in the year-to-year susceptibility of BRD pathogens to tilmicosin, a new macrolide antimicrobial agent, was observed. The proportion of susceptible P. haemolytica isolates ranged from 84.7% in the second year to 7.1% in the third year and 78.2% in the fourth year. Similar fluctuations were observed with strains of P. multocida.

This article has been cited by other articles:

• McDermott, P. F., Barry, A. L., Jones, R. N., Stein, G. E., Thornsberry, C., Wu, C. C., Walker, R. D. (2001). Standardization of Broth Microdilution and Disk Diffusion Susceptibility Tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: Quality Control Standards for Ceftiofur, Enrofloxacin, Florfenicol, Gentamicin, Penicillin, Tetracycline, Tilmicosin, and Trimethoprim-Sulfamethoxazole. J. Clin. Microbiol. 39: 4283-4287 [Abstract] [Full Text]  
• Loubinoux, J., Lozniewski, A., Lion, C., Garin, D., Weber, M., Le Faou, A. E. (1999). Value of Enterobacterial Repetitive Intergenic Consensus PCR for Study of Pasteurella multocida Strains Isolated from Mouths of Dogs. J. Clin. Microbiol. 37: 2488-2492 [Abstract] [Full Text]  
• Kehrenberg, C., Werckenthin, C., Schwarz, S. (1998). Tn5706, a Transposon-Like Element from Pasteurella multocida Mediating Tetracycline Resistance. Antimicrob. Agents Chemother. 42: 2116-2118 [Abstract] [Full Text]  
• Jarvinen, L. Z., Hogenesch, H., Suckow, M. A., Bowersock, T. L. (1998). Induction of Protective Immunity in Rabbits by Coadministration of Inactivated Pasteurella multocida Toxin and Potassium Thiocyanate Extract. Infect. Immun. 66: 3788-3795 [Abstract] [Full Text]